A Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia
Clinical trial NCT02952092 · COMPLETED
Trial details
- NCT number
- NCT02952092
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-30
- Primary completion
- 2018-03-13
- Enrollment
- 303
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.